Form 8-K - Current report:
SEC Accession No. 0001104659-13-087875
Filing Date
2013-12-02
Accepted
2013-12-02 16:15:23
Documents
2
Period of Report
2013-11-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-25232_18k.htm 8-K 27502
2 EX-10.1 a13-25232_1ex10d1.htm EX-10.1 55693
  Complete submission text file 0001104659-13-087875.txt   84152
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 131252003
SIC: 2834 Pharmaceutical Preparations